Cargando…
Safety and effectiveness of the sodium‐glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus
BACKGROUND: Bexagliflozin is a sodium‐glucose cotransporter 2 (SGLT2) inhibitor. A pilot study has shown that bexagliflozin can decrease dependence on exogenous insulin in cats with diabetes mellitus (DM). OBJECTIVE: To evaluate the safety and effectiveness of bexagliflozin as a monotherapy for DM i...
Autores principales: | Hadd, Michael J., Bienhoff, Stephen E., Little, Susan E., Geller, Samuel, Ogne‐Stevenson, Jennifer, Dupree, Thomas J., Scott‐Moncrieff, J. Catharine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229323/ https://www.ncbi.nlm.nih.gov/pubmed/37148170 http://dx.doi.org/10.1111/jvim.16730 |
Ejemplares similares
-
Comparison of 2 assays for measuring serum total thyroxine concentration in dogs and cats
por: Wolff, Ewan D. S., et al.
Publicado: (2020) -
Radioactive iodine uptake in hyperthyroid cats after administration of recombinant human thyroid stimulating hormone
por: Oberstadt, Amy E., et al.
Publicado: (2018) -
Effect of the Glucagon‐like Peptide‐1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus
por: Riederer, A., et al.
Publicado: (2016) -
Effect of Feeding an Iodine‐Restricted Diet in Cats with Spontaneous Hyperthyroidism
por: Hui, T.Y., et al.
Publicado: (2015) -
Glycemic variability in newly diagnosed diabetic cats treated with the glucagon‐like peptide‐1 analogue exenatide extended release
por: Krämer, Anna L., et al.
Publicado: (2020)